Svaks Biotech India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.25 M
- Company Age 21 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 583655.67%
- Profit Growth 30927.66%
- Ebitda 46473.51%
- Net Worth 257.25%
- Total Assets 419.50%
About Svaks Biotech India
Svaks Biotech India Private Limited (SBIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 July 2003 and has a history of 21 years and six months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.25 M, as per Ministry of Corporate Affairs (MCA) records.
Amruta Karangutkar and Pandurang Shirke serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24230MH2003PTC141395
- Company No.
141395
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2003
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Svaks Biotech India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amruta Karangutkar  | Director | 07-Jul-2021 | Current |
| Pandurang Shirke | Director | 07-Apr-2021 | Current |
Financial Performance of Svaks Biotech India.
Svaks Biotech India Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 583655.67% increase. The company also saw a substantial improvement in profitability, with a 30927.66% increase in profit. The company's net worth Soared by an impressive increase of 257.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Svaks Biotech India?
In 2021, Svaks Biotech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Svaks Biotech India?
Svaks Biotech India has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Svaks Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Svaks Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
